How FDA Should Use Its Authority to Regulate Human Cells
FDA should encourage states to be the primary regulators of stem cell procedures.
Andrew Ittleman
Andrew S. Ittleman is a founder and partner of Fuerst Ittleman David & Joseph, PL, where he concentrates his practice in the areas of white collar defense, anti-money laundering compliance, and food and drug law.